SEC Filing Summary: Heatwurx, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Heatwurx, Inc. on October 21, 2013. The registrant is incorporated in Delaware and operates from Greenwood Village, Colorado. Note: The input metadata referenced "Processa Pharmaceuticals, Inc.," but the filing text explicitly identifies the registrant as Heatwurx, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The material event reported is the granting of a patent by the U.S. Patent and Trademark Office for Heatwurx equipment. This intellectual property milestone was announced via a press release dated October 21, 2013.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management outlook, or specific risk factors. The document serves solely to disclose the patent grant under Regulation FD. The press release detailing the patent is attached as Exhibit 99.1 but is furnished, not filed, for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific scope and claims of the patent granted to Heatwurx equipment by reviewing the attached press release (Exhibit 99.1).
- Confirm the commercial applicability of the patented technology to the company's current product line.
- Check subsequent filings for any financial impact or revenue recognition related to this intellectual property.